127 related articles for article (PubMed ID: 10803931)
1. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
Bohlen H; Kessler M; Sextro M; Diehl V; Tesch H
Ann Hematol; 2000 Mar; 79(3):110-3. PubMed ID: 10803931
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Sarris AH; Kliche KO; Pethambaram P; Preti A; Tucker S; Jackow C; Messina O; Pugh W; Hagemeister FB; McLaughlin P; Rodriguez MA; Romaguera J; Fritsche H; Witzig T; Duvic M; Andreeff M; Cabanillas F
Ann Oncol; 1999 Apr; 10(4):433-40. PubMed ID: 10370786
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
[TBL] [Abstract][Full Text] [Related]
5. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
Gorschlüter M; Bohlen H; Hasenclever D; Diehl V; Tesch H
Ann Oncol; 1995 May; 6(5):477-82. PubMed ID: 7545429
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Visco C; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Medeiros LJ; Notti P; Rassidakis GZ; Peethambaram P; Wilder R; Witzig T; Gianni M; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Leuk Lymphoma; 2004 Oct; 45(10):2085-92. PubMed ID: 15370254
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
Gause A; Scholz R; Klein S; Jung W; Diehl V; Tesch H; Hasenclever D; Pfreundschuh M
Hematol Oncol; 1991; 9(6):307-13. PubMed ID: 1748397
[TBL] [Abstract][Full Text] [Related]
8. Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Viviani S; Notti P; Bonfante V; Verderio P; Valagussa P; Bonadonna G
Med Oncol; 2000 Feb; 17(1):59-63. PubMed ID: 10713662
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
Lymphokine Cytokine Res; 1992 Apr; 11(2):109-13. PubMed ID: 1581417
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
[TBL] [Abstract][Full Text] [Related]
11. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.
Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
Ann Oncol; 2000 Nov; 11(11):1405-11. PubMed ID: 11142480
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
13. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Rassidakis GZ; Doussis-Anagnostopoulou IA; Hatzioannou M; Vaiopoulos G; Kittas C; Sarris AH; Pizzolo G; Pangalis GA
Haematologica; 2001 Mar; 86(3):274-81. PubMed ID: 11255274
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
15. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma.
Salgami EV; Efstathiou SP; Vlachakis V; Sekara EV; Syrigos KN; Roussou PP
Haematologia (Budap); 2002; 32(4):377-87. PubMed ID: 12803112
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of cytokines in patients with Hodgkin's disease.
Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
18. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.
Trümper L; Jung W; Dahl G; Diehl V; Gause A; Pfreundschuh M
Ann Oncol; 1994; 5 Suppl 1():93-6. PubMed ID: 8172827
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-10 in non-Hodgkin's lymphoma.
Cortes J; Kurzrock R
Leuk Lymphoma; 1997 Jul; 26(3-4):251-9. PubMed ID: 9322887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
